96 weeks of pegylated Interferon alpha 2a plustenofovir or placebo for the treatment of hepatitis delta the HIDIT 2 study


Wedemeyer H. , YURTAYDIN S. C. , Ernst S., Caruntu F., Curescu M. G. , YALÇIN K., ...More

AASLD 2013, 1 - 05 November 2013

  • Publication Type: Conference Paper / Full Text